Skip to Main Content

Author Details

Robin Hamilton
Moorfields Eye Hospital NHS Foundation Trust
1998
65
21
PMIDPaper TitleJournal TitlePublished Year
37491441Efficacy and Safety outcomes of a novel model to assess new medical retina referrals in a high-volume medical retina virtual clinic.Eye (Lond)2024
35973593Diabetic Macular Edema and Diode Subthreshold Micropulse Laser: A Randomized Double-Masked Noninferiority Clinical Trial.Ophthalmology2023
37318668Comparison of anatomical and functional outcomes of treating myopic choroidal neovascularization with bevacizumab or ranibizumab.Int Ophthalmol2023
37109349A Multi-Modal AI-Driven Cohort Selection Tool to Predict Suboptimal Non-Responders to Aflibercept Loading-Phase for Neovascular Age-Related Macular Degeneration: PRECISE Study Report 1.J Clin Med2023
37373573Visual and Anatomical Outcomes of a Single Intravitreal Dexamethasone in Diabetic Macular Edema: An 8 Year Real-World Study.J Clin Med2023
36496461Exploring regression to the mean in visual acuities by investigating measurements at two consecutive time points in untreated fellow eyes.Eye (Lond)2023
34172943Intravitreal injections: past trends and future projections within a UK tertiary hospital.Eye (Lond)2022
35468601Fluid Control in Neovascular Age-Related Macular Degeneration with Brolucizumab: An Analysis of the HAWK and HARRIER Phase 3 Trials.Ophthalmologica2022
35428639Estimating excess visual loss from neovascular age-related macular degeneration in the UK during the COVID-19 pandemic: a retrospective clinical audit and simulation model.BMJ Open2022
35484812Treatment of chronic diabetic macular oedema with intravitreal fluocinolone acetonide implant; real-life analysis of outcomes during overall treatment period.Eur J Ophthalmol2022
36541393Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.Health Technol Assess2022
36644455Letter to Editor: Prophylactic Use of Nonsteroidal Anti-Inflammatory Drugs after Cataract Surgery and Corneal Melt.J Curr Ophthalmol2022
33692537Medical retina hotline: Service evaluation and assessment of efficacy of a novel system in a tertiary care hospital.Eye (Lond)2022
35314774The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practice.Eye (Lond)2022
34923515EFFECT OF RETINAL THICKNESS VARIABILITY ON VISUAL OUTCOMES AND FLUID PERSISTENCE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Post Hoc Analysis of the HAWK and HARRIER Studies.Retina2022
32193221Widefield optical coherence tomography angiography for early detection and objective evaluation of proliferative diabetic retinopathy.Br J Ophthalmol2021
33875826Prefilled Eylea Syringe: our recent experience.Eye (Lond)2021
33128024A virtual-clinic pathway for patients referred from a national diabetes eye screening programme reduces service demands whilst maintaining quality of care.Eye (Lond)2021
32591734An open-source data set of anti-VEGF therapy in diabetic macular oedema patients over 4 years and their visual acuity outcomes.Eye (Lond)2021
32586117Four-year outcomes of aflibercept treatment for neovascular age-related macular degeneration: Results from real-life setting.Eur J Ophthalmol2021
32429690Intravitreal aflibercept for diabetic macular oedema in real-world: 36-month visual acuity and anatomical outcomes.Eur J Ophthalmol2021
32452251One-year real-life results on effect of intravitreal aflibercept in patients with diabetic macular oedema switched from ranibizumab.Eur J Ophthalmol2021
30808179Intravitreal aflibercept for diabetic macular oedema: Moorfields' real-world 12-month visual acuity and anatomical outcomes.Eur J Ophthalmol2020
31961888Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study.PLoS One2020
31980748Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration.Eye (Lond)2020
33378369Ranibizumab treatment patterns in prior ranibizumab-treated neovascular age-related macular degeneration patients: Real-world outcomes from the LUMINOUS study.PLoS One2020
32699378Correction: Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group.Eye (Lond)2020
32504038Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group.Eye (Lond)2020
32546938Providing a Safe and Effective Intravitreal Treatment Service: Strategies for Service Delivery.Clin Ophthalmol2020
32405045The impact of COVID policies on acute ophthalmology services-experiences from Moorfields Eye Hospital NHS Foundation Trust.Eye (Lond)2020
32557168Individualizing Therapy for Neovascular Age-Related Macular Degeneration with Aflibercept (VITAL): A Two-Year Prospective, Interventional Single-Centre Trial.Ophthalmol Ther2020
31383649Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study.Br J Ophthalmol2020
29324593INCIDENCE AND LONG-TERM VISUAL ACUITY OUTCOMES OF RETINAL PIGMENT EPITHELIUM TEARS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.Retina2019
31564370Unravelling the mechanism of combined cilioretinal artery and retinal vein occlusion: documentation of the oscillating blood flow column and a review of the literature.Can J Ophthalmol2019
31044734Clinical Outcomes of a Hospital-Based Teleophthalmology Service: What Happens to Patients in a Virtual Clinic?Ophthalmol Retina2019
30755274Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial.Trials2019
29306863Implementation of medical retina virtual clinics in a tertiary eye care referral centre.Br J Ophthalmol2018
29982914Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting.Ophthalmol Ther2018
30198971Reply.Retina2018
29768451Intravitreal ocriplasmin for the treatment of vitreomacular traction and macular hole- A study of efficacy and safety based on NICE guidance.PLoS One2018
27746298Long-Term Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration in a Clinical Setting.Am J Ophthalmol2017
28478396UK AMD/DR EMR REPORT IX: comparative effectiveness of predominantly as needed (PRN) ranibizumab versus continuous aflibercept in UK clinical practice.Br J Ophthalmol2017
28212876Risk of Posterior Capsule Rupture During Cataract Surgery in Eyes With Previous Intravitreal Injections.Am J Ophthalmol2017
28024646Reply.Am J Ophthalmol2017
27914628Reply.Am J Ophthalmol2017
26906165Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration: A Randomized Controlled Study.Ophthalmology2016
27637784Real-World Outcomes of Ranibizumab Treatment for Diabetic Macular Edema in a United Kingdom National Health Service Setting.Am J Ophthalmol2016
27289179Predictors of Outcome in Patients with Neovascular Age-Related Macular Degeneration Switched from Ranibizumab to 8-Weekly Aflibercept.Ophthalmology2016
25277302The incidence of serious complications associated with intravitreal therapy in a quaternary ARMD service (2008-2014).Eye (Lond)2015
26291265Exploring Sex and Laterality Imbalances in Patients Undergoing Laser Retinopexy.JAMA Ophthalmol2015
  • 1 - 50 of 65

Recommended Authors

Thais F Conti
Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic
Career Start Year 2018
Number of shared co-authors 3
Vaidehi S Dedania
Department of Ophthalmology at NYU Grossman School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Kyle V Marra
the Scripps Research Institute
Career Start Year 2013
Number of shared co-authors 2
Xihui Lin
Kresge Eye Institute/Wayne State University Department of Ophthalmology
Career Start Year 2012
Number of shared co-authors 0
Miranda Buckle
University of Oxford
Career Start Year 2009
Number of shared co-authors 6
Vincent Daien
University Hospital Montpellier
Career Start Year 2009
Number of shared co-authors 13
Javier Zarranz-Ventura
Hospital Clinic of Barcelona, University of Barcelona
Career Start Year 2008
Number of shared co-authors 28
Daniel L Chao
Shiley Eye Institute, University of San Diego
Career Start Year 2007
Number of shared co-authors 0
Adam R Glassman
Jaeb Center for Health Research
Career Start Year 2006
Number of shared co-authors 2
Christopher M Aderman
Wills Eye Hospital
Career Start Year 2006
Number of shared co-authors 2
Daniel Barthelmes
University Hospital Zurich and University of Zurich
Career Start Year 2006
Number of shared co-authors 13
Caio V Regatieri
Universidade Federal de Sao Paulo
Career Start Year 2006
Number of shared co-authors 0
Katherine E Talcott
Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic
Career Start Year 2005
Number of shared co-authors 3
Lisa C Olmos de Koo
University of Washington
Career Start Year 2005
Number of shared co-authors 4
Yasha S Modi
New York University School of Medicine, New York University Langone Health
Career Start Year 2004
Number of shared co-authors 1
Jay M Stewart
University of California san francisco
Career Start Year 2002
Number of shared co-authors 2
Alastair K Denniston
University Hospitals Birmingham NHS Foundation Trust
Career Start Year 2000
Number of shared co-authors 36
Igor Kozak
Moorfields Eye Hospital Dubai.
Career Start Year 1999
Number of shared co-authors 5
Glenn Yiu
University of California davis
Career Start Year 1998
Number of shared co-authors 2
Vuong Nguyen
The University of Sydney Save Sight Institute
Career Start Year 1998
Number of shared co-authors 4
Sunir J Garg
The Retina Service of Wills Eye Hospital
Career Start Year 1998
Number of shared co-authors 5
Judy E Kim
Medical College of Wisconsin
Career Start Year 1994
Number of shared co-authors 4
Timothy W Olsen
Mayo Clinic
Career Start Year 1993
Number of shared co-authors 2
Michael G Morley
Harvard Medical School
Career Start Year 1992
Number of shared co-authors 0
Allen C Ho
Wills Eye Hospital/Mid Atlantic Retina
Career Start Year 1992
Number of shared co-authors 3
Quan Dong Nguyen
Byers Eye Institute, Stanford University
Career Start Year 1990
Number of shared co-authors 5
Michael W Stewart
Mayo Clinic
Career Start Year 1988
Number of shared co-authors 3
Mark C Gillies
The University of Sydney Save Sight Institute
Career Start Year 1987
Number of shared co-authors 17
Michele Melia
Jaeb Center for Health Research
Career Start Year 1984
Number of shared co-authors 1
Neil M Bressler
Wilmer Eye Institute, Johns Hopkins University School of Medicine
Career Start Year 1979
Number of shared co-authors 9

Collaborators

Praveen J Patel
NIHR Moorfields Biomedical Research Centre
Co-authored papers 15
Sobha Sivaprasad
NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital
Co-authored papers 14
Dawn A Sim
Institute of Ophthalmology, University College London
Co-authored papers 9
Faruque Ghanchi
Bradford Teaching Hospitals NHS Foundation Trust
Co-authored papers 9
Louise Downey
Hull and East Yorkshire Hospital, Hull and East Yorkshire NHS Trust
Co-authored papers 8
Pearse A Keane
Moorfields Eye Hospital NHS Foundation Trust
Co-authored papers 8
Catherine Egan
Moorfields Eye Hospital NHS Foundation Trust
Co-authored papers 8
Konstantinos Balaskas
University of Manchester
Co-authored papers 8
Clare Bailey
Bristol Eye Hospital
Co-authored papers 7
Geeta Menon
Frimley Health NHS Foundation Trust
Co-authored papers 6
Frank G Holz
University of Bonn
Co-authored papers 6
Haralabos Eleftheriadis
Kings College Hospital NHS Foundation Trust
Co-authored papers 5
Richard Gale
Hull York Medical School, University of York
Co-authored papers 5
Stephen J Talks
Newcastle Hospitals NHS Foundation Trust
Co-authored papers 5
Tunde Peto
Queen's University Belfast
Co-authored papers 3
Michel Michaelides
Institute of Ophthalmology, University College London
Co-authored papers 3
Karsten Kortuem
Universitatsklinikum Ulm
Co-authored papers 3
Adnan Tufail
Moorfields Eye Hospital NHS Foundation Trust
Co-authored papers 3
Dun Jack Fu
Research Centre, Moorfields Eye Hospital NHS Foundation Trust
Co-authored papers 3
Livia Faes
Eye Clinic, Cantonal Hospital of Lucerne
Co-authored papers 3
Catey Bunce
Royal Marsden NHS Foundation Trust
Co-authored papers 3
Roy Schwartz
Moorfields Eye Hospital NHS Foundation Trust
Co-authored papers 2
Siegfried K Wagner
Institute of Ophthalmology, University College London
Co-authored papers 2
Richard David Leslie
Blizard Institute, Barts and Royal London Medical School
Co-authored papers 2
Hemal Mehta
The University of Sydney Save Sight Institute
Co-authored papers 2
Sajjad Mahmood
University of Manchester
Co-authored papers 2
Carlos Pavesio
Moorfields Eye Hospital NHS Foundation Trust
Co-authored papers 2
Andrew C Browning
Royal Victoria Infirmary
Co-authored papers 2
Martin McKibbin
Leeds Teaching Hospitals NHS Trust
Co-authored papers 2
Andrew J Lotery
University of Southampton
Co-authored papers 2
Release 1.2